Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 8/20 | 0.62 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.59 |
| ▸ | ABL1 | P00519 | 3/20 | 0.56 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.56 |
| ▸ | BCR | P11274 | 3/20 | 0.56 |
| ▸ | KIF11 | P52732 | 2/20 | 0.55 |
| ▸ | ANPEP | P15144 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | MMP3 | P08254 | 1/20 | 0.46 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.45 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9280477 | 1.00 | ESR1 (0.62) | ESR1ESR2ABL1ABCB1BCR | |
| SCHEMBL17108385 | 0.87 | ANPEP (0.42) | ESR1ESR2KIF11ANPEPHSD17B1 | |
| SCHEMBL13104729 | 0.85 | ESR1 (0.67) | ESR1ESR2ABL1ABCB1BCR | |
| SCHEMBL1254675 | 0.85 | ESR1 (0.52) | ESR1ESR2KIF11MEN1KMT2A | |
| SCHEMBL18388215 | 0.85 | ESR1 (0.52) | ESR1ESR2KIF11MEN1KMT2A | |
| Phenol SCHEMBL27463236 | 0.84 | MMP3 (0.52) | ESR1ESR2ABL1ABCB1BCR | |
| SCHEMBL20821889 | 0.83 | ESR1 (0.55) | ESR1ESR2KIF11MEN1KMT2A | |
| SCHEMBL13628948 | 0.83 | ESR2 (0.52) | ESR1ESR2ABL1ABCB1BCR | |
| SCHEMBL13105050 | 0.81 | ESR1 (0.56) | ESR1ESR2ABL1ABCB1BCR | |
| SCHEMBL1630267 | 0.81 | ESR1 (0.79) | ESR1ESR2ABL1ABCB1BCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11193063-B2 | Compound, liquid crystal composition and photoelectric display device thereof | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-12-07 | — | — | US | disclosed |
| US-20210179940-A1 | WIDE TEMPERATURE RANGE AND HIGH PHOTOCHEMICAL STABILITY SMECTIC LIQUID CRYSTAL COMPOSITIONS WITH A MONOLAYER SMECTIC A PHASE (SMA1), METHOD OF OBTAINING THEREOF AND DEVICES UTILIZING THEREOF | WOJSKOWA AKADEMIA TECHNICZNA (PL) | 2021-06-17 | — | — | US | disclosed |
| US-20200255738-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION AND PHOTOELECTRIC DISPLAY DEVICE THEREOF | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-08-13 | — | — | US | disclosed |
| CN-110981699-A | Improvement of synthesis process of 3,4, 5-trifluorophenol | 蚌埠中实化学技术有限公司 | 2020-04-10 | — | — | CN | disclosed |
| CN-110563764-A | electrolyte flame-retardant additive and preparation method and application thereof | 恒大新能源科技集团有限公司 | 2019-12-13 | — | — | CN | disclosed |
| CN-103328516-B | Activated carrier | 英尼奥斯欧洲股份公司 | 2019-06-28 | — | — | CN | disclosed |
| US-20120313041-A1 | FOUR-RING COMPOUND HAVING A PLURALITY OF CF2O BONDING GROUPS, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-12-13 | — | — | US | disclosed |
| US-20120313041-A1 | FOUR-RING COMPOUND HAVING A PLURALITY OF CF2O BONDING GROUPS, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-12-13 | — | — | US | disclosed |
| US-7314943-B2 | Pyran derivatives containing an exocyclic double bond | MERCK PATENT GMBH (DE) | 2008-01-01 | — | — | US | disclosed |
| US-7314943-B2 | Pyran derivatives containing an exocyclic double bond | MERCK PATENT GMBH (DE) | 2008-01-01 | — | — | US | disclosed |
| US-20050038267-A1 | Pyran derivatives containing an exocyclic double bond | MERCK PATENT GMBH (DE) | 2005-02-17 | — | — | US | disclosed |
| EP-0786445-B1 | DIFLUOROXYMETHANE DERIVATIVE AND LIQUID CRYSTAL COMPOSITION | CHISSO CORP (JP) | 2002-07-17 | — | — | EP | disclosed |
| EP-0786509-B1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | CHISSO CORP (JP) | 2001-09-12 | — | — | EP | disclosed |
| EP-0786508-B1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | CHISSO CORP (JP) | 2001-01-17 | — | — | EP | disclosed |
| US-5858270-A | Difluorooxymethane derivative and liquid crystal composition | CHISSO CORPORATION (JP) | 1999-01-12 | — | — | US | disclosed |
| US-5792386-A | A MIXTURE OF ALKYLCYCLOHEXYL(PHENYLENE)DIFLUROMETHOXY-BENZENES AND FLUORO-CONTAINING COMPOUNDS; LOW VISCOSITY; LOW TEMPERATURE MISCIBILITY; HEAT AND CHEMICAL RESISTANCE; ACTIVE MATRIX | CHISSO CORPORATION (JP) | 1998-08-11 | — | — | US | disclosed |
| US-5728319-A | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 1998-03-17 | — | — | US | disclosed |
| EP-0786509-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | CHISSO CORPORATION (JP) | 1997-07-30 | — | — | EP | disclosed |
| EP-0786508-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | CHISSO CORPORATION (JP) | 1997-07-30 | — | — | EP | disclosed |
| EP-0786445-A1 | DIFLUOROXYMETHANE DERIVATIVE AND LIQUID CRYSTAL COMPOSITION | CHISSO CORPORATION (JP) | 1997-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11193063-B2 | Compound, liquid crystal composition and photoelectric display device thereof | FES, LMTK3, LMTK2 | ESR1 1108/4885ESR2 3378/4885ABL1 342/4885 |
| US-20050038267-A1 | Pyran derivatives containing an exocyclic double bond | EXOC1, EDF1, EIF4A1 | ESR1 1711/4885ESR2 300/4885ABL1 2880/4885 |
| US-20200255738-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION AND PHOTOELECTRIC DISPLAY DEVICE THEREOF | FES, LMTK3, LMTK2 | ESR1 1108/4885ESR2 3378/4885ABL1 342/4885 |
| US-20120313041-A1 | FOUR-RING COMPOUND HAVING A PLURALITY OF CF2O BONDING GROUPS, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | OCIAD2, OCIAD1, POU2F2 | ESR1 2638/4885ESR2 1984/4885ABL1 2757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.